Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Rules of evidence for cancer molecular-marker discovery and validation.

Ransohoff DF.

Nat Rev Cancer. 2004 Apr;4(4):309-14. Review. No abstract available.

PMID:
15057290
[PubMed - indexed for MEDLINE]
2.

Biomarker boom slowed by validation concerns.

Benowitz S.

J Natl Cancer Inst. 2004 Sep 15;96(18):1356-7. No abstract available.

PMID:
15367567
[PubMed - indexed for MEDLINE]
Free Article
3.

Antibody arrays: technical considerations and clinical applications in cancer.

Sanchez-Carbayo M.

Clin Chem. 2006 Sep;52(9):1651-9. Epub 2006 Jun 29. Review.

PMID:
16809399
[PubMed - indexed for MEDLINE]
Free Article
4.

The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.

Tejpar S.

Best Pract Res Clin Gastroenterol. 2007;21(6):1071-87. Review.

PMID:
18070704
[PubMed - indexed for MEDLINE]
5.

Criteria for tumor marker evaluation and utilization.

Fleisher M.

MLO Med Lab Obs. 2003 Apr;35(4):16-8; quiz 20-1. No abstract available.

PMID:
12705209
[PubMed - indexed for MEDLINE]
6.

Tumor markers in cancer diagnosis and prognosis.

Virji MA, Mercer DW, Herberman RB.

CA Cancer J Clin. 1988 Mar-Apr;38(2):104-26. Review. No abstract available.

PMID:
3127000
[PubMed - indexed for MEDLINE]
7.

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Camp RL, Neumeister V, Rimm DL.

J Clin Oncol. 2008 Dec 1;26(34):5630-7. doi: 10.1200/JCO.2008.17.3567. Epub 2008 Oct 20. Review.

PMID:
18936473
[PubMed - indexed for MEDLINE]
8.

Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.

Hellberg D, Tot T, Stendahl U.

Gynecol Oncol. 2009 Jan;112(1):235-40. doi: 10.1016/j.ygyno.2008.09.013. Epub 2008 Oct 30.

PMID:
18976801
[PubMed - indexed for MEDLINE]
9.

How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.

Ransohoff DF.

J Clin Epidemiol. 2007 Dec;60(12):1205-19. Epub 2007 Sep 24. Review.

PMID:
17998073
[PubMed - indexed for MEDLINE]
10.

Tumor marker utility grading system.

Prentice RL.

J Natl Cancer Inst. 1996 Oct 16;88(20):1419-20. No abstract available.

PMID:
8841012
[PubMed - indexed for MEDLINE]
11.

How to judge a tumor marker.

Katz EM, Kattan MW.

Nat Clin Pract Oncol. 2005 Oct;2(10):482-3. Review. No abstract available.

PMID:
16205748
[PubMed - indexed for MEDLINE]
12.

[Markers for diagnosis, prediction and prognosis of prostate cancer].

Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S.

Tidsskr Nor Laegeforen. 2005 Dec 1;125(23):3279-82. Norwegian.

PMID:
16327854
[PubMed - indexed for MEDLINE]
Free Article
13.

Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.

Henry NL, Hayes DF.

Oncologist. 2006 Jun;11(6):541-52. Review.

PMID:
16794234
[PubMed - indexed for MEDLINE]
Free Article
14.

Detecting common gene expression patterns in multiple cancer outcome entities.

Yang X, Bentink S, Spang R.

Biomed Microdevices. 2005 Sep;7(3):247-51.

PMID:
16133813
[PubMed - indexed for MEDLINE]
15.

Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.

Brenner DE, Normolle DP.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1918-20. No abstract available.

PMID:
17932336
[PubMed - indexed for MEDLINE]
Free Article
16.

Toward cancer biomarker discovery using the glycomics approach.

Taniguchi N.

Proteomics. 2008 Aug;8(16):3205-8. doi: 10.1002/pmic.200890056. No abstract available.

PMID:
18690642
[PubMed - indexed for MEDLINE]
17.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

Harris AL.

Br J Cancer. 2005 Aug 22;93(4):385-6. No abstract available.

PMID:
16106244
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Protein chips and nanomaterials for application in tumor marker immunoassays.

Chen H, Jiang C, Yu C, Zhang S, Liu B, Kong J.

Biosens Bioelectron. 2009 Aug 15;24(12):3399-411. doi: 10.1016/j.bios.2009.03.020. Epub 2009 Mar 24. Review.

PMID:
19398322
[PubMed - indexed for MEDLINE]
19.

Standards for reporting prognostic tumor marker studies.

Alonzo TA.

J Clin Oncol. 2005 Dec 20;23(36):9053-4. Epub 2005 Nov 21. No abstract available.

PMID:
16301590
[PubMed - indexed for MEDLINE]
20.

[Molecular markers having a prognostic or therapeutic value in cancer].

Brousset P.

Ann Pathol. 2008 Nov;28 Spec No 1(1):S69-70. doi: 10.1016/j.annpat.2008.09.021. Epub 2008 Oct 15. French. No abstract available.

PMID:
18984307
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk